NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Yes, that is exactly my point. Having a general contract that provides a plan for scaling on demand is from my read, what the regulators would want to see, not necessarily an immediate scaling like Dendreon did, which spend huge sums years before those facilities were needed.

However, once Flaskworks is approved, their better expansion plan will likely incorporate that technology, which is something these other companies do not have. The one company that will be familiar with the technology is Advent and Advent also does not have its own facilities, so they are flexible enough to manage and resource NWBO’s facilities. That is a very useful relationship and I think that will expand.